Proteome Sciences PLC 2017 AR2
The report outlines Proteome Sciences plc's financial and operational performance for the year ended December 31, 2017. The company experienced a 23% increase in revenue to £3.38m, driven by strong sales and royalties of its isobaric tandem mass tag (TMT) reagents. Operationally, the company consolidated its laboratory facilities in Frankfurt and relocated its headquarters to London to improve efficiency and connectivity. Proteome Sciences also achieved Good Clinical Laboratory Practice (GCLP) accreditation, enhancing its capacity to compete for clinical-stage contracts.
Company: Proteome Sciences PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2017
Type: AR2
Pages: 72
Back to company
Proteome Sciences PLC
Report And Financial Statements
The report outlines Proteome Sciences plc's financial and operational performance for the year ended December 31, 2017. The company experienced a 23% increase in revenue to £3.38m, driven by strong sales and royalties of its isobaric tandem mass tag (TMT) reagents. Operationally, the company consolidated its laboratory facilities in Frankfurt and relocated its headquarters to London to improve efficiency and connectivity. Proteome Sciences also achieved Good Clinical Laboratory Practice (GCLP) accreditation, enhancing its capacity to compete for clinical-stage contracts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees